(Q34193315)

31 July 2017

title

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis (English)

1 reference

31 July 2017

1 reference

Jonathan S Wall

1

1 reference

31 July 2017

Stephen J Kennel

2

1 reference

31 July 2017

Alan C Stuckey

3

1 reference

31 July 2017

Misty J Long

4

1 reference

31 July 2017

David W Townsend

5

1 reference

31 July 2017

Gary T Smith

6

1 reference

31 July 2017

Karen J Wells

7

1 reference

31 July 2017

Yitong Fu

8

1 reference

31 July 2017

Michael G Stabin

9

1 reference

31 July 2017

Deborah T Weiss

10

1 reference

31 July 2017

Alan Solomon

11

1 reference

31 July 2017

language of work or name

English

0 references

publication date

3 June 2010

1 reference

31 July 2017

number of pages

4

1 reference

inferred from page(s)

published in

Blood

1 reference

31 July 2017

volume

116

1 reference

31 July 2017

issue

13

1 reference

31 July 2017

page(s)

2241-2244

1 reference

Splenic plasma cells can serve as a source of amyloidogenic light chains

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Characterization of systemic amyloid deposits by mass spectrometry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Molecular mechanisms of amyloidosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Autologous stem cell transplantation for primary systemic amyloidosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Antibody-mediated resolution of light chain-associated amyloid deposits.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Technetium-99m-antiepidermal growth factor-receptor antibody in patients with tumors of epithelial origin: part II. Pharmacokinetics and clearances.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Amyloidosis: prognosis and treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2953836

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

28 October 2018

1 reference

12 December 2020

Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis

1 reference

12 December 2020

A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis

1 reference

12 December 2020

High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

1 reference

12 December 2020

10.1182/BLOOD-2010-03-273797

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference